Clinical trials: Primary Parkinsonism
Cognition, Parkinson's Disease
Turkish Validation of the Parkinson Disease Cognitive Functional Rating Scale
The aim of the present study is to translate the Parkinson's Disease-Cognitive Functional Rating Scale into Turkish (PD-CFRS-Turkish version) and to evaluate its validity and reliability.
- Conditions
- Cognition, Parkinson's Disease, Reliability and Validity, Cognitive Functions
- Trial name
- NCT07253376
- Where
- 2 sites in Turkey (Türkiye)
- Volunteers
- 60 people
- Sponsor
- Gazi University
Parkinson Disease
Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's Disease
Participants are randomly allocated to one of two treatment groups. In one group, participants are given capsules of simvastatin to take orally (by mouth) for 24 months.
- Trial name
- PD STAT (NCT02787590)
- Testing
- Simvastatin
- Where
- 24 sites in United Kingdom
- Volunteers
- 235 people
- Sponsor
- University Hospital Plymouth NHS Trust
Dysphagia
Nicergoline Use in Dysphagia Patients
Dysphagia is a complication in patient with stroke, Parkinson's disease or dementia that can lead to aspiration pneumonia. This study aimed to investigate dysphagia improvement after treatment with nicergoline low dose and high…
- Trial name
- NCT05551182
- Testing
- Nicergoline
- Where
- Thailand
- Volunteers
- 92 people
- Sponsor
- Phramongkutklao College of Medicine and Hospital
Mild Cognitive Impairment (MCI) Amnestic, Parkinson Disease (PD)
Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)
The study aims to phenotype hearing in patients with early stage of neurodegenerative disorders to explore the prevalence of various hearing disorders in comparison to a control population.
- Conditions
- Mild Cognitive Impairment (MCI) Amnestic, Parkinson Disease (PD), Healthy Participants
- Trial name
- SAPHIR (NCT07083089)
- Testing
- Thorough Hearing assessment
- Where
- 4 sites in France
- Volunteers
- 309 people, healthy volunteers welcome
- Sponsor
- Cilcare SAS
Coronary Heart Disease, Anemia
The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
Study is conducted to assess the prevalence and structure of comorbidity among patients undergoing abdominal surgery and produce the stratification of the risk of postoperative complications by identifying independent predictors…
- Conditions
- Coronary Heart Disease, Anemia, Bronchial Asthma, Stroke
- Trial name
- STOPRISK (NCT03945968)
- Where
- 38 sites in Russia
- Volunteers
- 16,000 people
- Sponsor
- Russian Federation of Anesthesiologists and Reanimatologists
Major Depressive Disorder, Idiopathic Parkinson Disease
Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease
This study aims to assess the tolerability of duloxetine, 60mg once daily, in open label fashion, in depressed patients with Parkinson's disease during 12 weeks treatment.
- Trial name
- NCT00437125
- Testing
- Duloxetine hydrochloride
- Where
- 13 sites in Italy
- Volunteers
- 151 people
- Sponsor
- Eli Lilly and Company
Parkinson Disease
Multimodal Neuromodulation in Individuals With Parkinson's Disease
Multimodal non-invasive neuromodulation paired with physical therapy is a promising treatment modality for Parkinson's Disease ("PD"), however the optimal stimulation method, dose, and associated therapeutic protocol for…
- Trial name
- NCT05105776
- Testing
- Galvanic stimulation
- Where
- Canada
- Volunteers
- 32 people
- Sponsor
- Ryan D'Arcy
Parkinson Disease, Cognitive Dysfunction
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)
The primary purpose of this two-part study was to evaluate the safety and tolerability of SAGE-718 and its effects on cognitive, neuropsychiatric, and motor symptoms in participants with Parkinson's disease mild cognitive…
- Trial name
- NCT04476017
- Testing
- SAGE-718
- Where
- 4 sites in United States
- Volunteers
- 18 people
- Sponsor
- Supernus Pharmaceuticals, Inc.
Parkinson Disease
A Clinical Study of IRL790 in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia
This is a Phase 1b study investigating the safety and tolerability of IRl790 as adjunct therapy in patients with Parkinson disease. IRL790/placebo is taken for 28 days.
- Trial name
- NCT03531060
- Testing
- IRL790
- Volunteers
- 15 people
- Sponsor
- Integrative Research Laboratories AB
Parkinson Disease
Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease
Observational cross-sectional study in PD patients and healthy controls (HC) using an investigational medical device consisting of a passive small intestine microbiome aspiration (SIMBA) system (capsule) that is ingested orally…
- Trial name
- SmIle (NCT06003608)
- Testing
- Fluid biopsy capsule, Levodopa-Carbidopa Immediate Release
- Where
- Canada
- Volunteers
- 51 people, healthy volunteers welcome
- Sponsor
- Nimble Science Ltd.
Parkinson Disease
Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease
The purpose of this study is to evaluate the efficacy, safety and tolerability of PF-06649751 in Parkinson's disease patients at early stage of the disease.
- Trial name
- NCT02847650
- Testing
- PF-06649751
- Where
- 37 sites in United States, France and 2 more
- Volunteers
- 57 people
- Sponsor
- Pfizer
Patients With Synucleinopathies, Neurogenic Orthostatic Hypotension
Natural History Study of Synucleinopathies
Synucleinopathies are a group of rare diseases associated with worsening neurological deficits and the abnormal accumulation of the protein α-synuclein in the nervous system. Onset is usually in late adulthood at age 50 or older.
- Conditions
- Patients With Synucleinopathies, Neurogenic Orthostatic Hypotension, Pure Autonomic Failure, REM Sleep Behavior Disorder
- Trial name
- NCT01799915
- Where
- 8 sites in United States, Argentina and 2 more
- Volunteers
- 800 people
- Sponsor
- NYU Langone Health
Parkinson's Disease
Study to Evaluate DNL151 in Subjects With Parkinson's Disease
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple oral doses of DNL151 in subjects with Parkinson's disease.
- Trial name
- NCT04056689
- Testing
- DNL151
- Where
- 8 sites in United States, Belgium and 2 more
- Volunteers
- 36 people
- Sponsor
- Biogen
Depression, Parkinson's Disease
The Effects of Sertraline on Depression in Parkinson's Disease
The aim of this open-label, self-control study is to evaluate the efficacy of sertraline in treating depression in Patients with Parkinson's disease.
- Trial name
- PD (NCT01437189)
- Testing
- Sertraline
- Where
- China
- Volunteers
- 35 people
- Sponsor
- Zhejiang University
Parkinsons Disease
Pilot Study Evaluating Safety of Unilateral Gamma Knife Subthalamotomy for Parkinson's Disease
This is a pilot study to evaluate the safety and efficacy of unilateral gamma knife subthalamotomy for Parkinson's disease in patients deemed poor candidates for deep brain stimulation.
- Trial name
- GKSTN (NCT02249559)
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- NYU Langone Health
Parkinson Disease
Pilot Study To Assess Effect of Treatment and Adherence in PD Subjects
The purpose of this study is to evaluate the impact of imaging the brain as a diagnostic tool in the management of early Parkinson's disease (PD).
- Trial name
- NCT01788696
- Testing
- Group A - Early Imaging, Group B - Delayed Imaging
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Duke University
Parkinson Disease Dementia
OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001
This is a Phase 2 open-label extension study to evaluate the effects of ANAVEX2-73 on safety and efficacy of daily treatment.
- Trial name
- NCT04575259
- Testing
- ANAVEX2-73
- Where
- 10 sites in Australia, Spain
- Volunteers
- 132 people
- Sponsor
- Anavex Life Sciences Corp.
Parkinson's Disease
Noninterventional Study Evaluating Parkinson's Disease Diary Use
This study aims to evaluate the impact of the frequency of assessments on the variability over time, reliability, and compliance for the Parkinson's disease (PD) diary in patients with PD in whom medications do not provide…
- Trial name
- NCT05363046
- Where
- 34 sites in United States, Canada and 3 more
- Volunteers
- 194 people
- Sponsor
- BlueRock Therapeutics
Parkinson's Disease
Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism
The primary objective of this protocol is to access the utility of 18F-DTBZ PET imaging as an in vivo biomarker to monitor neurodegeneration of both PD mouse models and PD patients.
- Trial name
- NCT01759888
- Testing
- 18F-DTBZ
- Where
- Taiwan
- Volunteers
- 49 people
- Sponsor
- Chang Gung Memorial Hospital
Parkinson's Disease
Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease
The purpose of the present research is to examine the effectiveness of a non-invasive, vibrotactile stimulation protocol, known as coordinated reset (CR), for the alleviation of motor symptoms in patients with Parkinson's disease…
- Trial name
- NCT05830110
- Testing
- Active Vibrotactile Coordinated Reset
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Synergic Medical Technologies, Inc.
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.